Perfluorohexyloctane and lotilaner ophthalmic solution, 2 ocular surface disease drugs, have changed the DED and DB treatment paradigms.
On December 16, 2024, the U.S. Food and Drug Administration (FDA) announced a nationwide recall affecting 136,181 bottles of ...
The global ophthalmic sprays market, valued at USD 343 million in 2023, is projected to experience exponential growth, ...
Kettering General Hospital (KGH) has set up a £250,000 state-of-the-art one-stop ophthalmology suite for patients who need injections in the eye.
FDA alerts and updates on the latest drug and device approvals, recalls, and other regulatory developments in ophthalmology.